Effects of carboxymethylcellulose and hydroxypropylmethylcellulose on the differentiation and activity of osteoclasts and osteoblasts
- 27 July 2010
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 95A (2) , 504-509
Abstract
Carboxymethylcellulose (CMC) and hydroxypropylmethylcellulose (HPMC) serve as carriers for growth factors and bone substitutes. Although both carriers are placed into the defect sites, their impacts on bone regeneration are unclear. Herein, we examined whether CMC and HPMC affect the differentiation of bone marrow progenitors into osteoclasts and osteoblasts. We therefore induced osteoclastogenesis and osteoblastogenesis in murine bone marrow progenitors in the presence of CMC and HPMC, respectively. Measures of osteoclastogesis were based on the number and activity of tartrate‐resistant acid‐phosphatase‐positive (TRAP+) multinucleated cells and expression of marker genes. Osteoblastogenesis was determined by the number and activity of alkaline‐phosphatase‐positive (AP+) colonies and relevant marker genes. Viability was assessed by colorimetric measurement of formazan formation. We report that CMC at 1% caused a significant reduction in the number and activity of TRAP+ multinucleated cells. Changes in viability were not responsible for the observed effects. HPMC showed no remarkable impact on osteoclastogenesis; however, the concentration was limited to 0.5% because of the high viscosity. The ability of bone marrow progenitors to form AP+ colonies was not affected by either of the two carriers. Together, these results suggest that CMC and possibly also HPMC can decrease osteoclastogenesis while osteoblastogenesis remains unchanged in vitro. These observations raise the possibility that these carriers might affect the cellular process of bone regeneration. © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.Keywords
This publication has 30 references indexed in Scilit:
- Comparative evaluation of different crystal‐structured calcium sulfates as bone‐filling materialsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2009
- Clinical Evaluation of the Combination of Anorganic Bovine‐Derived Hydroxyapatite Matrix/Cell‐Binding Peptide (P‐15) in Particulate and Hydrogel Form as a Bone Replacement Graft Material in Human Periodontal Osseous Defects: 6‐Month Reentry Controlled Clinical StudyJournal of Periodontology, 2007
- In vitro testing of Advanced JAX™ Bone Void Filler System: species differences in the response of bone marrow stromal cells to β tri-calcium phosphate and carboxymethylcellulose gelJournal of Materials Science: Materials in Medicine, 2007
- Calcium sulfate–carboxymethylcellulose bone graft binder: Histologic and morphometric evaluation in a critical size defectJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cellsBiomaterials, 2006
- Bone repair using a new injectable self-crosslinkable bone substituteJournal of Orthopaedic Research, 2006
- Bone defect healing with an osteogenic protein‐1 device combined with carboxymethylcelluloseJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Fast‐setting calcium phosphate scaffolds with tailored macropore formation rates for bone regenerationJournal of Biomedical Materials Research Part A, 2004
- Evaluation of carboxymethylcellulose, hydroxypropylmethylcellulose, and aluminum hydroxide as potential carriers for rhBMP-2Journal of Biomedical Materials Research, 2001
- The Evaluation of Lyophilized Polymer Matrices for Administering Recombinant Human Bone Morphogenetic Protein-2Pharmaceutical Development and Technology, 1996